References
- Albasri A, El-Siddig A, Hussainy A, et al (2014). Histopathologic characterization of prostate diseases in Madinah, Saudi Arabia. Asian Pac J Cancer Prev, 15, 4175. https://doi.org/10.7314/APJCP.2014.15.10.4175
- Amoori N, Mirzaei M, Cheraghi M (2014). Incidence of cancers in kuzestan province of Iran: Trend from 2004 to 2008. Asian Pac J Cancer Prev, 15, 8345-9. https://doi.org/10.7314/APJCP.2014.15.19.8345
- Arshad H, Ahmad Z (2013). Overview of benign and malignant prostatic disease in Pakistani patients: a clinical and histopathological perspective. Asian Pac J Cancer Prev, 14, 3005-10. https://doi.org/10.7314/APJCP.2013.14.5.3005
- Autorino R, Di Lorenzo G, Damiano R, et al (2009). Pathology of the prostate in radical cystectomy specimens: a critical review. Surgical Oncol, 18, 73-84. https://doi.org/10.1016/j.suronc.2008.07.006
- Baade PD, Youlden DR, Krnjacki LJ (2009). International epidemiology of prostate cancer: geographical distribution and secular trends. Molecular nutrition Food Res, 53, 171-84. https://doi.org/10.1002/mnfr.200700511
- Basiri A, Shakhssalim N, Jalaly NY, et al (2014). Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran. Asian Pac J Cancer Prev, 15, 1459-63. https://doi.org/10.7314/APJCP.2014.15.3.1459
- Belbase NP, Agrawal CS, Pokharel PK, et al (2013). Prostate cancer screening in a healthy population cohort in Eastern Nepal: an explanatory trial study. Asian Pac J Cancer Prev, 14, 2835-8. https://doi.org/10.7314/APJCP.2013.14.5.2835
- Bray F, Lortet-Tieulent J, Ferlay J, et al (2010). Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer, 46, 3040-52. https://doi.org/10.1016/j.ejca.2010.09.013
- Eser S, Yakut C, Ozdemir R, et al (2009). Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev, 11, 1731-9.
- Esmail Nasab N MG, Zareie M, et al (2007). Survey of epidemilogic status and incidence rates of cancers in the patients above 15 years old in Kurdistan province. SJKUMS, 11, 18-25.
- Farahmand M, Almasi-Hashiani A, Mehrabani D (2013). The epidemiologic study of prostate cancer in Fars province, Southern Iran (2003-2008). Arak Med U J, 15, 54-60.
- Fatemah Haghighi , Ali Habibi, Tavakoli M (2005). Epidemiological retrospective study of neoplasms of prostate gland in Birjand (South Khorasan province). J Birjand U Med Sci, 12, 9-15.
- Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. https://doi.org/10.1002/ijc.29210
- Fritz AG (2000). International classification of diseases for oncology: ICD-O, World Health Organization.
- Goya M (2007). Iranian Annual Cancer Registration Report 2005/2006. Ministry of Health and Medical Education, Health Deputy. Center Disease Control Prevention (in Persian).
- Grivas N, Hastazeris K, Kafarakis V, et al (2012). Prostate cancer epidemiology in a rural area of North Western Greece. Asian Pac J Cancer Prev, 13, 999-1002. https://doi.org/10.7314/APJCP.2012.13.3.999
- Gronberg H (2003). Prostate cancer epidemiology. Lancet, 361, 859-64. https://doi.org/10.1016/S0140-6736(03)12713-4
- Hahiyan K, Firozjahi A, Taghkiya M (2003). Pattern of Age Distribution of Different Cancers Babol, 2001. Pejouhesh, 27, 239-45.
- Hosseini S, Danesh A, Parvin M, et al (2007). Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J urol, 33, 167-75. https://doi.org/10.1590/S1677-55382007000200006
- Jack RH, Davies EA, Moller H (2010). Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South East England. BJU Int, 105, 1226-30. https://doi.org/10.1111/j.1464-410X.2009.08940.x
- Jamali M, Moghadam K (1996). Statistical study and review of prostatic latent carcinoma. Tehran U Med J, 54, 37-41.
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, et al (2015). Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev, 16, 1409-13. https://doi.org/10.7314/APJCP.2015.16.4.1409
- Kim HJ, Fay MP, Feuer EJ, et al (2000). Permutation tests for joinpoint regression with applications to cancer rates. Statistics Med, 335-51.
- Masoompour SM, Yarmohammadi H, Rezaianzadeh A, et al (2011). Cancer incidence in southern Iran, 1998-2002: Results of population-based cancer registry. Cancer Epidemiol, 35, 42-7. https://doi.org/10.1016/j.canep.2011.05.018
- Mehrabani D, Tabei S, Heydari S, et al (2008). Cancer occurrence in fars province, southern Iran. Iranian Red Crescent Med J, 10, 314-22.
- Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
- Muir C, Nectoux J, Staszewski J (1991). The epidemiology of prostatic cancer: geographical distribution and time-trends. Acta Oncologica, 30, 133-40. https://doi.org/10.3109/02841869109092336
- Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al (2015). The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int, 3, 135-40. https://doi.org/10.1016/j.prnil.2015.09.001
- Pourmand G, Salem S, Mehrsai A, et al (2007). The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev, 8, 422.
- Radmard AR (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
- Sadjadi A, Nooraie M, Ghorbani A, et al (2007). The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med, 10, 481-5.
- Zorlu F, Zorlu R, Divrik R, et al (2014). Prostate cancer incidence in Turkey: an epidemiological study. Asian Pac J Cancer Prev, 15, 9125-30. https://doi.org/10.7314/APJCP.2014.15.21.9125
Cited by
- Analysis of Cancer Incidence and Mortality in Iran Using Joinpoint Regression Analysis vol.19, pp.3, 2016, https://doi.org/10.5812/ircmj.42071
- Effects of Thymoquinone on IL-6 Gene Expression and Some Cellular Signaling Pathways in Prostate Cancer PC3 Cells vol.12, pp.3, 2017, https://doi.org/10.5812/jjnpp.63753
- Detection of HPV genotypes and their association with p53 codon 72 polymorphism in prostate cancer vol.12, pp.6, 2017, https://doi.org/10.2217/fvl-2017-0001
- Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis pp.1099498X, 2018, https://doi.org/10.1002/jgm.3053
- Western Dietary Pattern, But not Mediterranean Dietary Pattern, Increases the Risk of Prostate Cancer pp.1532-7914, 2018, https://doi.org/10.1080/01635581.2018.1490779
- Is Propionibacterium acnes a Causative Agent in Benign Prostate Hyperplasia and Prostate Cancer? vol.13, pp.3, 2018, https://doi.org/10.5812/archcid.58947
- The role of blood neutrophil count and the neutrophil-to-lymphocyte ratio as a predictive factor for prostate biopsy results pp.1724-6075, 2018, https://doi.org/10.1177/0391560318766822
- Relationship between nutrients intake and the risk of prostate cancer vol.48, pp.4, 2018, https://doi.org/10.1108/NFS-01-2018-0003